Short Interest in Arteris, Inc. (NASDAQ:AIP) Increases By 70.6%

Key Points

• Arteris, Inc. experienced a significant increase in short interest, with a total of 1,860,000 shares sold short as of August 15th, representing a 70.6% increase from July's figures.
• Research analysts currently have an average rating of "Buy" for Arteris with a target price of $15.00, indicating a positive outlook for the stock.
• Insiders at Arteris have sold a total of 492,989 shares in the last three months, leading to a current insider ownership of 29.10% of the company.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) was the target of a large increase in short interest during the month of August. As of August 15th, there was short interest totaling 1,860,000 shares, an increase of 70.6% from the July 31st total of 1,090,000 shares. Based on an average daily trading volume, of 1,010,000 shares, the days-to-cover ratio is currently 1.8 days. Approximately 6.6% of the shares of the stock are short sold. Approximately 6.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,010,000 shares, the days-to-cover ratio is currently 1.8 days.

Insider Buying and Selling at Arteris

In related news, Director Saiyed Atiq Raza sold 63,118 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $13.07, for a total value of $824,952.26. Following the completion of the transaction, the director owned 590,000 shares in the company, valued at $7,711,300. This trade represents a 9.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Laurent R. Moll sold 8,129 shares of the firm's stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $8.74, for a total value of $71,047.46. Following the transaction, the chief operating officer owned 386,552 shares of the company's stock, valued at $3,378,464.48. This trade represents a 2.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 510,616 shares of company stock worth $5,979,663 over the last quarter. 29.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Squarepoint Ops LLC lifted its stake in shares of Arteris by 143.8% in the 2nd quarter. Squarepoint Ops LLC now owns 120,957 shares of the company's stock valued at $1,153,000 after acquiring an additional 71,340 shares during the last quarter. Marex Group plc bought a new stake in shares of Arteris in the 2nd quarter valued at about $395,000. State of Wyoming bought a new position in Arteris during the 2nd quarter valued at approximately $455,000. Bank of America Corp DE raised its position in Arteris by 11.8% during the 2nd quarter. Bank of America Corp DE now owns 57,093 shares of the company's stock valued at $544,000 after purchasing an additional 6,008 shares during the last quarter. Finally, Ameriprise Financial Inc. bought a new position in Arteris during the 2nd quarter valued at approximately $742,000. Institutional investors own 64.36% of the company's stock.

Arteris Stock Up 3.1%

Shares of NASDAQ:AIP traded up $0.27 during midday trading on Thursday, reaching $8.93. 363,339 shares of the company traded hands, compared to its average volume of 530,949. Arteris has a 12 month low of $5.46 and a 12 month high of $14.29. The firm has a market capitalization of $380.86 million, a price-to-earnings ratio of -10.89 and a beta of 1.44. The firm's fifty day moving average price is $9.49 and its two-hundred day moving average price is $8.22.

Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The business had revenue of $16.50 million during the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts forecast that Arteris will post -0.73 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Rosenblatt Securities reaffirmed a "buy" rating and set a $14.00 target price on shares of Arteris in a research note on Wednesday, May 21st. Wall Street Zen cut Arteris from a "hold" rating to a "sell" rating in a research report on Sunday. Finally, TD Cowen lifted their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $15.00.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.